In January 2026, OpenAI quietly crossed a Rubicon. ChatGPT—the friendly AI that once felt like a glimpse into a utopian future—began testing advertisements. For free-tier users, and even those paying ...

Claims that molecular markers can accurately diagnose cancer have recently been disputed; some prominent results have not been reproduced and bias has been proposed to explain the original ...